VSee Health stockholders approve directors and equity plan

An announcement from VSee Health ( (VSEE) ) is now available.

On December 30, 2025, VSee Health, Inc. held its annual meeting of stockholders for the fiscal year ended December 31, 2025, with 35.74% of voting power represented, enough to constitute a quorum. Stockholders elected Dr. Milton Chen and Dr. Imoigele Aisiku as Class I directors to serve until the 2028 annual meeting, ratified WWC, P.C. as independent auditor for the 2025 fiscal year, approved the 2025 Equity Incentive Plan, and authorized the potential adjournment of the meeting, though this adjournment proposal was ultimately withdrawn because all other proposals passed. The outcomes solidify the company’s governance structure, maintain continuity in its auditing relationship, and provide a refreshed equity compensation framework, which together support management’s ability to retain talent and pursue its strategic objectives on a stable shareholder-approved footing.

The most recent analyst rating on (VSEE) stock is a Hold with a $0.37 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.

Spark’s Take on VSEE Stock

According to Spark, TipRanks’ AI Analyst, VSEE is a Neutral.

The score is primarily held down by weak financial fundamentals—ongoing losses, negative operating cash flow, and especially negative equity. Technicals are also bearish with the stock below major moving averages, despite oversold signals. The recent financing event is a modest positive for liquidity, but does not fully offset the underlying financial instability.

To see Spark’s full report on VSEE stock, click here.

More about VSee Health

Average Trading Volume: 13,939,958

Technical Sentiment Signal: Sell

Current Market Cap: $12.43M

For an in-depth examination of VSEE stock, go to TipRanks’ Overview page.